News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Imagion Biosystems.
RELATED STOCKHEAD STORIES
Health & Biotech
Health Check: Sleep-maker Resmed recovers from ‘nonsense’ sell-off spurred by rise of fat-busting drugs
Health & Biotech
Health Check: Thirsty Chimeric goes to the well for funding top-up
News
Closing Bell: Arcadium holders cash in, Oil rallies as Milton hits, and GYG keeps momentum going
Health & Biotech
Imagion raises $3m to advance MagSense cancer diagnosis platform
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
ASX Health Stocks: Imagion and Microba’s positive Phase 1 results; and LGP’s first mover advantage in France
Health & Biotech
ASX Health Stocks: Noxopharm jumps +50pc on mRNA vaccine results; Starpharma +25pc on Phase 2 study
News
ASX Small Caps Lunch Wrap: Who spent $150k on a piece of violent hip-hop history today?
News
ASX Small Caps Lunch Wrap: Who else should try to lose some risk appetite today?
News
ASX Small Caps and IPO Weekly Wrap: 30 hours of hot ASX action and we’re right back where we started
News
Rise and Shine: Everything you need to know before the ASX opens
News
CLOSING BELL: The RBA’s interest rate lever pulling finally pays off, sending the ASX up 1.1%
News
ASX Small Caps and IPO Weekly Wrap: ASX falls 1.1% for the week, an ass-kicking we probably didn’t deserve
News
Rise and Shine: Everything you need to know before the ASX opens
News
CLOSING BELL: Investors respond to the government’s Critical Minerals Strategy by selling everything in sight
News
In Case You Missed It: Biotech swoops in for the win today
News
